Novo Nordisk adds that the pill is manufactured end-to-end in the U.S
Compounded options: Compounded Semaglutide Injections (starting at $299/month) Compounded Tirzepatide Injections (starting at $399/month) GLP-1 Liquid Drops GLP-1 Lozenges Oral Semaglutide Liposomal Tablets FDA-approved options: Wegovy Pen (once-weekly injection, starting at $199/month through Shed) Wegovy Pill / Foundayo (once-daily oral tablet, starting at $149/month) Zepbound (via LillyDirect after provider approval) The needle-free formats, including drops, lozenges, and oral tablets, are particularly relevant for people who find injections to be a significant barrier
In a systematic review of 55 double-blinded, placebo-controlled randomized clinical trials, GLP-1RA treatment was associated with an increased risk of cholelithiasis compared with placebo (RR 1.46, 95% CI 1.091.97) but not cholecystitis, cholangitis, or pancreatitis (63)
Metabolic improvements: Additional benefits noted in research settings include reduction in waist circumference, improved lipid profiles, and decreased markers of insulin resistance
They increase insulin secretion in response to meals and reduce glucagon secretion, leading to more stable blood sugar control
GLP-1 is a powerful tool to help you lose weight, but long-term success depends on the lifestyle changes you make while on the medication
